LIVER TRANSPLANTATION (LT) RESULTS IN REDUCED RECIPIENT NATURAL KILLER (NK) CELL ACTIVATION WITH ASSOCIATED DOWN REGULATION OF ACTIVATING RECEPTORS NKP30 AND NKP46 BUT NOT NKG2D

被引:0
|
作者
Jamil, K. M. [1 ]
Cheent, K. S. [1 ]
Agarwal, K. [2 ]
Alexander, G. J. [3 ]
Heneghan, M. A. [2 ]
Khakoo, S. I. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England
[2] Kings Coll Hosp London, London SE5 8RX, England
[3] Addenbrookes Hosp, Cambridge, England
关键词
D O I
10.1136/gutjnl-2011-300857a.100
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P100
引用
下载
收藏
页码:A46 / A47
页数:6
相关论文
共 42 条
  • [31] Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30
    Kellner, Christian
    Guenther, Andreas
    Humpe, Andreas
    Repp, Roland
    Klausz, Katja
    Derer, Stefanie
    Valerius, Thomas
    Ritgen, Matthias
    Brueggemann, Monika
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Kneba, Michael
    Gramatzki, Martin
    Peipp, Matthias
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [32] Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies with CD20-Specific Immunoligands Engaging NKG2D or NKp30
    Peipp, Matthias
    Kellner, Christian
    Guenther, Andreas
    Humpe, Andreas
    Repp, Roland
    Klausz, Katja
    Derer, Stefanie
    Valerius, Thomas
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Gramatzki, Martin
    BLOOD, 2014, 124 (21)
  • [33] Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways
    Park, Arum
    Yang, Yunjeong
    Lee, Yunhee
    Kim, Mi Sun
    Park, Young-Jun
    Jung, Haiyoung
    Kim, Tae-Don
    Lee, Hee Gu
    Choi, Inpyo
    Yoon, Suk Ran
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [34] Day 100 Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cell Receptors Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas
    Porrata, Luis
    Ansell, Stephen M.
    Micallef, Ivana
    Johnston, Patrick B.
    Villasboas, J. C. C.
    Paludo, Jonas
    Durani, Urshila
    Markovic, Svetomir
    BLOOD, 2023, 142
  • [35] NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype:: regulation by histamine and reactive oxygen species
    Romero, AI
    Thorén, FB
    Brune, M
    Hellstrand, K
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (01) : 91 - 98
  • [36] NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype:: regulation by histamine and reactive oxygen species
    Romero, A
    Thorén, F
    Movitz, C
    Betten, Å
    Hellstrand, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, : 69 - 69
  • [37] Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity
    Thomas, Mair
    Boname, Jessica M.
    Field, Sarah
    Nejentsev, Sergey
    Salio, Mariolina
    Cerundolo, Vincenzo
    Wills, Mark
    Lehner, Paul J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) : 1656 - 1661
  • [38] The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell function
    Della Chiesa, Mariella
    Carlomagno, Simona
    Frumento, Guido
    Balsamo, Mirna
    Cantoni, Claudia
    Conte, Romana
    Moretta, Lorenzo
    Moretta, Alessandro
    Vitale, Massimo
    BLOOD, 2006, 108 (13) : 4118 - 4125
  • [39] Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients
    Martinovic, Katarina M. Mirjacic
    Babovic, Nada Lj.
    Dzodic, Radan R.
    Jurisic, Vladimir B.
    Tanic, Nikola T.
    Konjevic, Gordana M.
    MELANOMA RESEARCH, 2014, 24 (04) : 295 - 304
  • [40] Ex Vivo Expanded NK Cells Mediate Highly Efficient and Rapid Killing of Ewing Sarcoma Cells Through Degranulation with Tumor Cytotoxicity Controlled by the NKG2D, DNAM-1, and NKp30 NK Receptors
    Karambelkar, Amrita D.
    Reger, Robert N.
    Carlsten, Mattias
    Childs, Richard W.
    BLOOD, 2015, 126 (23)